Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Indian Science
  4. Volume 2, Issue 1
  5. Article
Volume 2, Issue 1
  • ISSN: 2210-299X
  • E-ISSN: 2210-3007
file format pdf download PDF
side by side viewer icon HTML

Abstract

Aim

This study aims to explore the binding interactions between synthesized 3,3’-Disubstituted Oxindoles and the HCK enzyme, with the specific goal of discovering potential anticancer agents.

Background

Cancer presents an ongoing global health challenge, necessitating the exploration of innovative therapeutic approaches. Isatin derivatives and pyridine compounds hold great promise for the development of anticancer drugs due to their wide-ranging biological activities. Moreover, HCK plays a significant role in chemotherapy resistance and reduced drug efficacy in clinical settings, highlighting its importance in the intricate network of cancer pathophysiology. There is an urgent need for targeted interventions to regulate HCK activity and enhance cancer treatment outcomes.

Methods

In our study, we ensured meticulous optimization of protein and ligand preparation to guarantee accurate docking simulations. We conducted molecular docking analyses using the state-of-the-art Glide module and assessed ADME properties using the Schrödinger suite's QikProp tool.

Results

Through molecular docking, compounds 3c and 3e have emerged as promising anticancer agents with low docking scores against Tyrosine Kinase. Further ADME analysis has provided valuable insights into the compounds' in-silico behaviour, while computed dipole moments have enhanced our understanding of their physicochemical characteristics.

Conclusion

In this study, we explored how the synthesized compounds bind within the HCK active site, indicating potential anticancer properties. Through docking, we identified compounds and as possible anticancer agents, with the lowest docking scores of -7.621 and -7.602 kcal/mol against Tyrosine Kinase. These findings emphasize the importance of computational approaches in drug discovery and offer valuable insights for future research and development efforts.

© 2024 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cis/10.2174/012210299X310595240626104426
2024-07-03
2025-03-01

  • From This Site

    /content/journals/cis/10.2174/012210299X310595240626104426
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
The full text of this item is not currently available.

References

  1. (a) PodarK. MostoslavskyG. SattlerM. TaiY.T. HayashiT. CatleyL.P. HideshimaT. MulliganR.C. ChauhanD. AndersonK.C. Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells.J. Biol. Chem.200427920216582166510.1074/jbc.M30578320015010462
     [Google Scholar]
  2. (b) GuietR. PoinclouxR. CastandetJ. MaroisL. LabrousseA. Le CabecV. Maridonneau-PariniI. Hematopoietic cell kinase (Hck) isoforms and phagocyte duties – From signaling and actin reorganization to migration and phagocytosis.Eur. J. Cell Biol.2008878-952754210.1016/j.ejcb.2008.03.00818538446
     [Google Scholar]
  3. (a) WangZ. YingC. ZhangA. XuH. JiangY. LouM. HCK promotes glioblastoma progression by TGFβ signaling.Biosci. Rep.2020406BSR2020097510.1042/BSR2020097532484210
     [Google Scholar]
  4. (b) Pene-DumitrescuT. ShuS.T. WalesT.E. AlvaradoJ.J. ShiH. NaruteP. MorocoJ.A. YehJ.I. EngenJ.R. SmithgallT.E. HIV-1 Nef interaction influences the ATP-binding site of the Src-family kinase, Hck.BMC Chem. Biol.201212111210.1186/1472‑6769‑12‑122420777
     [Google Scholar]
  5. RoversiF.M. PericoleF.V. Machado-NetoJ.A. da Silva Santos DuarteA. LonghiniA.L. CorrocherF.A. PalodettoB. FerroK.P. RosaR.G. BarattiM.O. Verjovski-AlmeidaS. TrainaF. MolinariA. BottaM. SaadS.T.O. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis.Biochim. Biophys. Acta Mol. Basis Dis.20171863245046110.1016/j.bbadis.2016.11.01327840303
     [Google Scholar]
  6. PohA.R. O’DonoghueR.J.J. ErnstM. Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.Oncotarget2015618157521577110.18632/oncotarget.419926087188
     [Google Scholar]
  7. KaurJ. KaurS. AnandA. IslamN. SinghS. SinghA. An updated overview on the synthesis and anticancer evaluation of quinazoline derivatives.ChemistrySelect2023830e20230277810.1002/slct.202302778
     [Google Scholar]
  8. GideonD.A. AnnaduraiP. NirusimhanV. ParasharA. JamesJ. DhayabaranV.V. Evaluation of the anticancer activities of isatin-based derivatives.Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. ChakrabortiS. SingaporeSpringer2022
     [Google Scholar]
  9. VarunV. SonamS. KakkarR. Isatin and its derivatives: A survey of recent syntheses, reactions, and applications.MedChemComm201910335136810.1039/C8MD00585K30996856
     [Google Scholar]
  10. KalirajanR. SankarS. JubieS. GowrammaB. Molecular docking studies and in-silico ADMET screening of some novel oxazine substituted 9-anilinoacridines as topoisomerase II inhibitors.Indian J Pharm Educ Res201751111011510.5530/ijper.51.1.15
     [Google Scholar]
  11. SinghP. KaurS. SharmaA. KaurG. BhattiR. TNF-α and IL-6 inhibitors: Conjugates of N-substituted indole and aminophenylmorpholin-3-one as anti-inflammatory agents.Eur. J. Med. Chem.20171409210310.1016/j.ejmech.2017.09.00328923390
     [Google Scholar]
  12. BoddyA.J. BullJ.A. Stereoselective synthesis and applications of spirocyclic oxindoles.Org. Chem. Front.2021851026108410.1039/D0QO01085E
     [Google Scholar]
  13. ChristodoulouM.S. NicolettiF. ManganoK. ChiacchioM.A. FacchettiG. RimoldiI. BeccalliE.M. GiofrèS. Novel 3,3-disubstituted oxindole derivatives. Synthesis and evaluation of the anti-proliferative activity.Bioorg. Med. Chem. Lett.202030212684510.1016/j.bmcl.2019.12684531831381
     [Google Scholar]
  14. PandaS.S. GirgisA.S. AzizM.N. BekheitM.S. Spirooxindole: A versatile biologically active heterocyclic scaffold.Molecules202328261810.3390/molecules2802061836677676
     [Google Scholar]
  15. YangY.T. ZhuJ.F. LiaoG. XuH.J. YuB. The development of biologically important spirooxindoles as new antimicrobial agents.Curr. Med. Chem.201825192233224410.2174/092986732566617112913131129189121
     [Google Scholar]
  16. HosseinzadehZ. Razzaghi-AslN. RamazaniA. AghahosseiniH. RamazaniA. Synthesis, cytotoxic assessment, and molecular docking studies of 2,6-diaryl-substituted pyridine and 3,4- dihydropyrimidine-2(1H)-one scaffolds.Turk. J. Chem.202044119421310.3906/kim‑1903‑7233488152
     [Google Scholar]
  17. AlbrattyM. AlhazmiH.A. Novel pyridine and pyrimidine derivatives as promising anticancer agents: A review.Arab. J. Chem.202215610384610.1016/j.arabjc.2022.103846
     [Google Scholar]
  18. El-NaggarM. AlmahliH. IbrahimH. EldehnaW. Abdel-AzizH. Pyridine-ureas as potential anticancer agents: Synthesis and in vitro biological evaluation.Molecules2018236145910.3390/molecules2306145929914120
     [Google Scholar]
  19. KaurJ. ChauhanP. SinghS. ChimniS.S. Journey heading towards enantioselective synthesis assisted by organocatalysis.Chem. Rec.201818213715310.1002/tcr.20170002028851023
     [Google Scholar]
  20. SunJ. ShenG. HuangY. YanC.G. Formation of diverse polycyclic spirooxindoles via three-component reaction of isoquinolinium salts, isatins and malononitrile.Sci. Rep.2017714102410.1038/srep4102428106130
     [Google Scholar]
  21. KaurS. KaurJ. IslamN. AnandA. Organocatalytic synthesis and DFT study of versatile biologically active scaffold of isatylidene malononitrile derivatives.ChemistrySelect2022742e20220389410.1002/slct.202203894
     [Google Scholar]
  22. KatsuraK. TomabechiY. MatsudaT. YonemochiM. MikuniJ. OhsawaN. TeradaT. YokoyamaS. Kukimoto-NiinoM. TakemotoC. ShirouzuM. Phosphorylated and non-phosphorylated HCK kinase domains produced by cell-free protein expression.Protein Expr. Purif.2018150929910.1016/j.pep.2018.05.00529793032
     [Google Scholar]
  23. GreenwoodJ.R. CalkinsD. SullivanA.P. ShelleyJ.C. Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution.J. Comput. Aided Mol. Des.2010246-759160410.1007/s10822‑010‑9349‑120354892
     [Google Scholar]
  24. ShelleyJ.C. CholletiA. FryeL.L. GreenwoodJ.R. TimlinM.R. UchimayaM. Epik: A software program for pK a prediction and protonation state generation for drug-like molecules.J. Comput. Aided Mol. Des.2007211268169110.1007/s10822‑007‑9133‑z17899391
     [Google Scholar]
  25. ShivakumarD. WilliamsJ. WuY. DammW. ShelleyJ. ShermanW. Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field.J. Chem. Theory Comput.2010651509151910.1021/ct900587b26615687
     [Google Scholar]
  26. JorgensenW.L. MaxwellD.S. Tirado-RivesJ. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids.J. Am. Chem. Soc.199611845112251123610.1021/ja9621760
     [Google Scholar]
  27. JorgensenW.L. Tirado-RivesJ. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin.J. Am. Chem. Soc.198811061657166610.1021/ja00214a00127557051
     [Google Scholar]
/content/journals/cis/10.2174/012210299X310595240626104426
Loading
Evaluation of 3, 3’-Disubstituted Oxindoles Derivatives as a Potential Anti-Cancer Tyrosine Kinase Inhibitors-molecular Docking and ADME Studies
Curr. Indian Sci. 2, e2210299X310595 (2024); https://doi.org/10.2174/012210299X310595240626104426
/content/journals/cis/10.2174/012210299X310595240626104426
/content/journals/cis/10.2174/012210299X310595240626104426
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): ADME studies; Inhibitors; Molecular docking; Oxindoles; Potential anti-cancer; Tyrosine kinase

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test